Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76251 - 76275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Liothyronine	Approved Investigational Vet Approved	KLF9	687	upregulated	Triiodothyronine results in increased expression of KLF9 mRNA	9q21.12	A24365 A20648 A21397
Liothyronine	Approved Investigational Vet Approved	LDLR	3949	upregulated	Triiodothyronine results in increased expression of LDLR mRNA	19p13.2	A20653
Liothyronine	Approved Investigational Vet Approved	LHX3	8022	downregulated	Triiodothyronine results in decreased expression of LHX3 mRNA	9q34.3	A20648
Liothyronine	Approved Investigational Vet Approved	LYRM9	201229	downregulated	Triiodothyronine results in decreased expression of LYRM9 mRNA	17q11.2	A20648
Liothyronine	Approved Investigational Vet Approved	MEIOC	284071	downregulated	Triiodothyronine results in decreased expression of MEIOC mRNA	17q21.31	A20648
Liothyronine	Approved Investigational Vet Approved	MIER3	166968	downregulated	Triiodothyronine results in decreased expression of MIER3 mRNA	5q11.2	A20648
Liothyronine	Approved Investigational Vet Approved	MMP11	4320	upregulated	Triiodothyronine results in increased expression of MMP11 mRNA	22q11.23	A24368
Liothyronine	Approved Investigational Vet Approved	NCAPG2	54892	downregulated	Triiodothyronine results in decreased expression of NCAPG2 mRNA	7q36.3	A20648
Liothyronine	Approved Investigational Vet Approved	PARP4	143	downregulated	Triiodothyronine results in decreased expression of PARP4 mRNA	13q12.12	A20648
Liothyronine	Approved Investigational Vet Approved	PCK1	5105	upregulated	Triiodothyronine results in increased expression of PCK1 mRNA	20q13.31	A24368
Liothyronine	Approved Investigational Vet Approved	PCSK1	5122	downregulated	Triiodothyronine results in decreased expression of PCSK1 mRNA	5q15	A24369
Liothyronine	Approved Investigational Vet Approved	PCSK2	5126	downregulated	Triiodothyronine results in decreased expression of PCSK2 mRNA	20p12.1	A20535
Liothyronine	Approved Investigational Vet Approved	PDK4	5166	upregulated	Triiodothyronine results in increased expression of PDK4 mRNA	7q21.3	A23911
Liothyronine	Approved Investigational Vet Approved	PEG10	23089	upregulated	Triiodothyronine results in increased expression of PEG10 mRNA	7q21.3	A20648
Liothyronine	Approved Investigational Vet Approved	PEX5	5830	upregulated	Triiodothyronine results in increased expression of PEX5 mRNA	12p13.31	A20648
Liothyronine	Approved Investigational Vet Approved	PFKP	5214	upregulated	Triiodothyronine results in increased expression of PFKP mRNA	10p15.2	A24365
Liothyronine	Approved Investigational Vet Approved	PLD5	200150	upregulated	Triiodothyronine results in increased expression of PLD5 mRNA	1q43	A20648
Liothyronine	Approved Investigational Vet Approved	PLXNC1	10154	upregulated	Triiodothyronine results in increased expression of PLXNC1 mRNA	12q22	A20648
Liothyronine	Approved Investigational Vet Approved	PSCA	8000	upregulated	Triiodothyronine results in increased expression of PSCA mRNA	8q24.3	A24367
Liothyronine	Approved Investigational Vet Approved	PSG7	5676	upregulated	Triiodothyronine results in increased expression of PSG7 mRNA	19q13.31	A24367
Liothyronine	Approved Investigational Vet Approved	RAB23	51715	downregulated	Triiodothyronine results in decreased expression of RAB23 mRNA	6p12.1-p11.2	A20648
Liothyronine	Approved Investigational Vet Approved	RAB3B	5865	upregulated	Triiodothyronine results in increased expression of RAB3B mRNA	1p32.3	A24365
Liothyronine	Approved Investigational Vet Approved	RHOV	171177	upregulated	Triiodothyronine results in increased expression of RHOV mRNA	15q15.1	A20648
Liothyronine	Approved Investigational Vet Approved	RNA18S5	100008588	upregulated	Triiodothyronine results in increased expression of RNA18S5 mRNA	22p12	A20648
Liothyronine	Approved Investigational Vet Approved	RPL22P11	402100	downregulated	Triiodothyronine results in decreased expression of RPL22P11 mRNA	2q13	A20648

Displaying entries 76251 - 76275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability